我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

干细胞治疗缺血性心脏病的分子影像评价

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第6期
页码:
727-729736
栏目:
综述
出版日期:
2014-06-25

文章信息/Info

Title:
Molecular imaging of stem cell-based therapy for ischemic heart disease
作者:
乔红玉; 李 霜; 曹 丰
(第四军医大学西京医院心内科，陕西 西安 710032)
Author(s):
QIAO Hong-yu;  LI Shuang;  CAO Feng
(Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
缺血性心脏病; 干细胞治疗; 干细胞; 分子影像
Keywords:
ischemic heart disease;  stem cell-based therapy;  stem cells;  molecular imaging
分类号:
R541
DOI:
-
文献标识码:
A
摘要:
缺血性心脏病(IHD)是目前世界范围内致病和致死的主要原因之一，干细胞(SC)作为一项潜在的治疗手段，成为当今实验室研究的热点，然而在研究过程中，遇到诸多问题：如SC在体的存活率不高及功能发挥不理想等。分子影像，包括多种多样的成像技术，一方面可以非侵入性的观察细胞，另一方面通过较长时间追踪细胞的转归和分化情况，指导优化SC治疗效果。本文将从以下3个方面介绍近年来在分子影像技术SC治疗IHD上的进展及突破：SC移植后在体内存活增殖的分子影像评估；移植SC在体功能的分子成像；针对SC治疗安全性的分子成像。最后，我们对分子影像的应用提出设想和展望。
Abstract:
Ischemic heart disease (IHD) is the leading cause of death worldwide. Stem cell (SC)-based therapy has shown great potentials as a treatment. Nevertheless, research results are not as promising as expected and many questions remain to be investigated such as SC monitoring and survival in vivo. The emergence and development of molecular imaging provides approaches to solve these problems via long-term tracking of the transplanted cells. In this article we reviewed the changes and breakthroughs in molecular imaging from three aspects: monitoring of SCs survival, assessment of SC function in vivo and safety of SC-based therapy. Finally, we express expectations for the future utility of molecular imaging.

参考文献/References

[1]Terrovitis J,Stuber M,Youssef A,et al.Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart[J].Circulation,2008,117(12):1555-1562.
[2]Malliaras K,Marbán E.Cardiac cell therapy:where we've been, where we are,and where we should be headed[J].Br Med Bull,2011,98(1):161-185.
[3]Wang J,Najjar A,Zhang S,et al.Molecular imaging of mesenchymal stem cell:mechanistic insight into cardiac repair after experimental myocardial infarction[J].Circ Cardiovasc Imaging,2012,5(1):94-101.
[4]Liu J,Chen D,Li X,et al.In vivo quantitative Reconstruction studies of bioluminescence tomography: effects of peak-wavelength shift and model deviation[J].IEEE Trans Biomed Eng,2010,57(10):2579-2582.
[5]Müller OJ,Schinkel S,Kleinschmidt JA,et al.Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats[J].Gene Ther,2008,15(23):1558-1565.
[6]Fan W,Sun D,Liu J,et al.Adipose stromal cells amplify angiogenic signaling via the VEGF/mTOR/Akt pathway in a murine hindlimb ischemia model:a 3D multimodality imaging study[J].PLoS One,2012,7(9):e45621.
[7]Templin C,Zweigerdt R,Schwanke K,et al.Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of Sodium iodide symporter transgene expression[J].Circulation,2012,126(4):430-439.
[8]Sun Z,Huang P,Tong G,et al.VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle[J].Nanoscale,2013,5(15):6857-6866.
[9]Cao F,Sun D,Li C,et al.Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up[J].Eur Heart J,2009,30(16):1986-1994.
[10]Sun D,Narsinh K,Wang H,et al.Effect of autologous bone marrow mononuclear cells transplantation in diabetic patients with ST-segment elevation myocardial infarction[J].Int J Cardiol,2013,167(2):537-547.
[11]Araki R,Uda M,Hoki Y,et al.Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells[J].Nature,2013,494(7435):100-104.
[12]Hattori F,Chen H,Yamashita H,et al.Nongenetic method for purifying stem cell-derived cardiomyocytes[J].Nat Methods,2010,7(1):61-66.
[13]Tohyama S,Hattori F,Sano M,et al.Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes[J].Cell Stem Cell,2013,12(1):127-137.
[14]Cao F,Li Z,Lee A,et al.Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation[J].Cancer Res,2009,69(7):2709-2713. （收稿日期：2014-03-10； 接受日期：2014-05-15）·综述·

备注/Memo

备注/Memo:
收稿日期：2014-03-10.
基金项目：国家杰出青年基金项目资助（81325009） 通讯作者：曹丰，教授，主要从事心肌再生的机制及干预的在体分子影像研究Email：wind8828@gmail.com
作者简介：乔红玉，博士生Email:qiaohongyu.1990@163.com
更新日期/Last Update: 2014-07-10